Metlife Inc (MET) 39.78 $MET After Yesterday's Rally of

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Metlife Inc (MET) 39.78 $MET

After Yesterday's Rally of 1.17% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 11, 1:43PM CDT
MetLife (NYSE:MET) traded in a range yesterday that spanned from a low of $39.42 to a high of $39.96. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $39.55 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MET: 39.78 (+0.58)

Look for Shares of MetLife to Potentially Pullback after Yesterday's 1.17% Rise
Comtex SmarTrend(R) - Mon Jul 11, 1:41PM CDT
MetLife (NYSE:MET) traded in a range yesterday that spanned from a low of $39.42 to a high of $39.96. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $39.55 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MET: 39.78 (+0.58)

MetLife Hong Kong Surges Ahead With Strong First-Half Performance
Marketwired - Fri Jul 08, 4:33AM CDT
Triple-Digit Growth Makes MetLife One of the Fastest Growing Life Insurers in Hong Kong
MET: 39.78 (+0.58)

MetLife Divests U.S Retail Advisory Force to MassMutual
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 5:23PM CDT
MetLife, Inc. (MET) has sold its U.S retail advisory force, Premier Client Group, to Massachusetts Mutual Life Insurance Company (MassMutual) for $165 million as per media release.
CI: 128.37 (-1.23), AIZ: 86.87 (+0.44), MET: 39.78 (+0.58), MTG: 6.12 (+0.08)

MetLife Declares Third Quarter 2016 Common Stock Dividend
BusinessWire - Thu Jul 07, 3:15PM CDT
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a third quarter 2016 common stock dividend of $0.40 per share. The dividend will be payable on Sept. 13, 2016, to shareholders of record as of Aug. 8, 2016.
MET: 39.78 (+0.58)

Watch for Shares of MetLife (MET) to Approach Support at $36.78
Comtex SmarTrend(R) - Wed Jul 06, 9:27AM CDT
MetLife (NYSE:MET) has opened bearishly below the pivot of $38.07 today and has reached the first level of support at $37.31. Should the shares continue to fall, the support pivots of $36.78 and $35.48 will be of interest.
MET: 39.78 (+0.58)

Allstate (ALL) Suffers from High Auto Claims, Cat Exposure
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:03AM CDT
Allstate (ALL) continues to suffer from increased claim severity and catastrophe losses.
MET: 39.78 (+0.58), AFG: 72.96 (-0.11), ALL: 69.94 (+0.28), AFL: 72.66 (+0.17)

5 Financial Stocks Being Crushed by Low Rates
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 2:56PM CDT
This low rate environment is a boon for borrowers. But the global financial sector is suffering.
NTRS: 65.03 (+0.50), MET: 39.78 (+0.58), KEY: 11.22 (+0.13), UNM: 31.30 (+0.10), SCHW: 25.78 (+0.05)

MetLife Set to Possibly Rebound After Yesterday's Selloff of 4.20%
Comtex SmarTrend(R) - Tue Jul 05, 12:53PM CDT
MetLife (NYSE:MET) traded in a range yesterday that spanned from a low of $37.54 to a high of $38.83. Yesterday, the shares fell 4.2%, which took the trading range below the 3-day low of $37.82 on volume of 5.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MET: 39.78 (+0.58)

Corporate Social Responsibility Related News Releases and Story Ideas for Reporters, Bloggers and Media Outlets
BusinessWire - Thu Jun 30, 7:08AM CDT
Following are the latest Corporate Social Responsibility news releases and story ideas available from Business Wire. These recaps, curated by Business Wire, provide reporters and bloggers around the globe instant access to the latest news releases, providing relevant and trending content to share with their audiences. Discover more news via Business Wire's Hot Topic recaps or create a custom news feed specific to your needs here. This service is provided at no charge to members of the media and financial communities.
HAS: 85.50 (+0.79), IHS: 116.00 (+2.03), ASX: 5.53 (+0.08), PRU: 71.81 (+0.82), UNH: 140.32 (-0.95), MET: 39.78 (+0.58), WMT: 74.06 (+0.22), WFC: 48.08 (+0.29), PX: 114.36 (-0.38)

PPG Signs Pension Transfer Agreement for 11,000 Retirees
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 6:24AM CDT
PPG Industries' (PPG) 11,000 retirees will be provided group annuities by MassMutual, per an agreement signed by both companies.
IOSP: 47.67 (+0.43), ALB: 83.63 (+0.05), MET: 39.78 (+0.58), PPG: 106.61 (+0.29)

GE Capital wins approval to drop 'too big to fail' label
By JOSEPH PISANI - AP - Wed Jun 29, 11:11AM CDT
NEW YORK (AP) — GE Capital is no longer "too big to fail."
GE: 32.21 (+0.01), PRU: 71.81 (+0.82), MET: 39.78 (+0.58), AIG: 53.29 (+0.28)

BetterInvesting Magazine Releases September Stock To Study And Undervalued Stock Choices For Investors' Informational And Educational Use
PR Newswire - Tue Jun 28, 3:15PM CDT
The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Bristol-Myers Squibb Company (NYSE: BMY) as its September 2016 "Stock to Study" and MetLife, Inc. (NYSE: MET), as its September 2016 "Undervalued Stock" for investors' informational and educational use.
MET: 39.78 (+0.58), BMY: 75.39 (+0.11)

MetLife, Massachusetts Mutual to Protect PPG Pension Risk
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 8:48AM CDT
MetLife (MET) along with Massachusetts Mutual Life Insurance Co. will reinsure longevity risks associated with pension obligations held by PPG Industries
PRU: 71.81 (+0.82), MET: 39.78 (+0.58), GM: 30.13 (+0.47), VZ: 55.93 (+0.03)

PPG to Transfer Pension Obligations to Insurance Companies
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 7:22AM CDT
PPG Industries Inc. (PPG) has agreed to transfer $1.6 billion of pension liabilities and obligations to Massachusetts Mutual Life Insurance Company (MassMutual) and MetLife, Inc. (MET).
IOSP: 47.67 (+0.43), ALB: 83.63 (+0.05), MET: 39.78 (+0.58), PPG: 106.61 (+0.29)

Look for Shares of MetLife to Potentially Rebound after Yesterday's 8.68% Sell Off
Comtex SmarTrend(R) - Fri Jun 24, 2:47PM CDT
MetLife (NYSE:MET) traded in a range yesterday that spanned from a low of $40.15 to a high of $41.47. Yesterday, the shares fell 8.7%, which took the trading range below the 3-day low of $42.21 on volume of 7.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MET: 39.78 (+0.58)

New Stock Research Reports for June 23, 2016
Sheraz Mian - Zacks Investment Research - Thu Jun 23, 12:51PM CDT
New Stock Research Reports for June 23, 2016
ISRG: 673.70 (-5.14), F: 13.27 (+0.18), IBM: 155.33 (+0.87), MET: 39.78 (+0.58), GM: 30.13 (+0.47), WY: 31.24 (+0.57), SRE: 114.29 (+0.18), AAPL: 96.98 (+0.30)

MetLife Releases Latest Corporate Responsibility Report
BusinessWire - Tue Jun 21, 12:02PM CDT
MetLife, Inc. (NYSE:MET) today announced the release of the company's latest corporate responsibility report, highlighting the positive impact the company makes on society and establishing goals for future activities.
MET: 39.78 (+0.58)

MetLife Rises 1.75% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jun 20, 4:34PM CDT
MetLife (NYSE:MET) traded in a range yesterday that spanned from a low of $42.79 to a high of $43.43. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $42.95 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MET: 39.78 (+0.58)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

LightBox CRE Activity Index Sees Positive Response to Rates

Updated Category News Views 67

Introduction to LightBox's Findings Recent insights from LightBox reveal significant shifts in the commercial real estate (CRE) sector, highlighting increased activity in response to recent economic changes. As a leading provider of CRE information and technology, LightBox's Monthly CRE Activity Index plays a crucial role in tracking the dynamics of the market....

Continue Reading
Alliance Pharma's Recent Trading Activity on the LSE Explored

Updated Category News Views 167

Understanding Alliance Pharma's Trading Activity Alliance Pharma plc, known for its strategic positioning in the pharmaceutical market, has made a significant impact through its recent trading activities. These transactions are crucial for understanding the company's current standing and future potential in the market. The firm operates under the stock ticker LSE:INVP,...

Continue Reading
Icon Energy Corp. Welcomes M/V Bravo and Secures Funding

Updated Category News Views 83

Icon Energy Corp. Welcomes M/V Bravo and Secures Financing Icon Energy Corp. (“Icon”) (Nasdaq: ICON) is thrilled to announce the arrival of its latest fleet member, the M/V Bravo, alongside significant financing aimed at facilitating future growth. This advanced Kamsarmax dry bulk carrier represents a key achievement in Icon's operational strategy, paving the way for...

Continue Reading
Coinbase Investor Alert: Class Action Lawsuit Filed Against Company

Updated Category News Views 403

Traders braced for turmoil as Coinbase Global, Inc. (NASDAQ: COIN) found itself entangled in a significant class action lawsuit back in 2024, brought forth by the reputable law firm Bronstein, Gewirtz & Grossman. This isn’t just another legal skirmish; it’s an alarm bell ringing loudly for investors who acquired Coinbase securities during the defined Class Period....

Continue Reading
Danny Go! Launches Exciting New Toy Line with Just Play

Updated Category News Views 447

Danny Go! Launches Exciting New Toy Line Three new active-play toys inspired by the beloved YouTube series, Danny Go!, are set to hit shelves just in time for the holiday season. This innovative collaboration between Danny Go! and Just Play, a prominent toy company, aims to engage children through play, song, and dance. Exciting Toy Debut at Walmart The launch of these...

Continue Reading